NATURAL CAPSULES
|
The Current P/E Ratio of NATURAL CAPSULES is -6.16.
| Share Price | ₹147.0 | Aug 19,2026 |
| Market Cap | ₹152.9 Cr | |
| Earnings-TTM | ₹-24.8 Cr | TTM-Consolidated Results |
| Price/Earnings | -6.16x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of NATURAL CAPSULES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹152.9 Cr] as on Aug 19,2026
(/) Earnings [ ₹-24.8 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -6.16x ]
Thus, for NATURAL CAPSULES , the investors are currently willing to pay -6.16 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NATURAL CAPSULES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NATURAL CAPSULES over the last five years.
Historical PE (Price/Earnings) ratio chart of NATURAL CAPSULES
PE Ratio Performance Analysis for NATURAL CAPSULES
- NATURAL CAPSULES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 80.65x.
- NATURAL CAPSULES 's operated at median p/e ratio of 23.63x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NATURAL CAPSULES 's p/e ratio peaked in Mar2025 at 308.54x.
- NATURAL CAPSULES 's p/e ratio hit its five-year low in Mar2026 of 0x.
How does NATURAL CAPSULES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| NATURAL CAPSULES | -24.83 | -6.16 | 152.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 37.41 | 455,394.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 77.37 | 226,312.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 88.44 | 190,678.0 |
| CIPLA LTD | 3,364.84 | 34.00 | 114,392.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.84 | 97,740.5 |
| MANKIND PHARMA LTD | 2,055.11 | 48.05 | 98,747.3 |
| LUPIN LTD | 5,551.01 | 18.29 | 101,506.0 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 24.54 | 110,224.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.03 | 92,932.2 |
| LAURUS LABS LTD | 1,090.76 | 89.51 | 97,634.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NATURAL CAPSULES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -6.16x |
| Max industry PE | 89.51x |
| Median industry PE | 34.00x |
| Average industry PE | 42.48x |
You may also like the below Video Courses